The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.EBI
Vanderbilt University School of Medicine
Towards a KCC2 blocker pharmacophore model.EBI
Ucb Pharma
Benzyl prolinate derivatives as novel selective KCC2 blockers.EBI
Ucb Pharma
Protein kinase inhibitorsBDB
Pharmascience
Factor XIA inhibitorsBDB
Merck Sharp & Dohme
Quinazolines as potassium ion channel inhibitorsBDB
Bristol-Myers Squibb
Amino-substituted heterocyclic derivatives as sodium channel inhibitorsBDB
Almirall
Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design.BDB
Pfizer
Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.BDB
Pfizer
Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors.BDB
Gsk